{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:32:24Z","timestamp":1785465144711,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073244"],"award-info":[{"award-number":["82073244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenyang Youth Science and Technology Innovation Talent Project","award":["RC200267"],"award-info":[{"award-number":["RC200267"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01176-1","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T06:50:51Z","timestamp":1737615051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends in Colorectal Cancer Peritoneal Metastases Research: A Comprehensive Bibliometric Analysis"],"prefix":"10.1007","volume":"56","author":[{"given":"Yuzhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"1176_CR1","first-page":"249","volume":"14","author":"L Hersz\u00e9nyi","year":"2010","unstructured":"Hersz\u00e9nyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 2010;14:249\u201358.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1176_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/1097-0142(197910)44:4<1476::AID-CNCR2820440442>3.0.CO;2-R","volume":"44","author":"Y Iitsuka","year":"1979","unstructured":"Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer. 1979;44:1476\u201380.","journal-title":"Cancer"},{"key":"1176_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/10717544.2019.1588423","volume":"26","author":"M Steuperaert","year":"2019","unstructured":"Steuperaert M, Debbaut C, Carlier C, De Wever O, Descamps B, Vanhove C, Ceelen W, Segers P. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy. Drug Delivery. 2019;26:404\u201315.","journal-title":"Drug Delivery"},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.tranon.2018.07.014","volume":"11","author":"S-C Kim","year":"2018","unstructured":"Kim S-C, Hong C-W, Jang S-G, Kim Y-A, Yoo B-C, Shin Y-K, Jeong S-Y, Ku J-L, Park J-G. Establishment and characterization of paired primary and peritoneal seeding human colorectal cancer cell lines: identification of genes that mediate metastatic potential. Transl Oncol. 2018;11:1232\u201343.","journal-title":"Transl Oncol"},{"key":"1176_CR5","first-page":"191","volume":"94","author":"P Jacquet","year":"1994","unstructured":"Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker P. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg. 1994;94:191\u20137.","journal-title":"Acta Chir Belg"},{"key":"1176_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YLB Klaver","year":"2012","unstructured":"Klaver YLB, Simkens LHJ, Lemmens VEPP, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IHJT, Punt CJA. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38:617\u201323.","journal-title":"Eur J Surg Oncol"},{"key":"1176_CR7","doi-asserted-by":"publisher","unstructured":"J F, Q S, Jp M, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol.2016. https:\/\/doi.org\/10.1016\/S1470-2045(16)30500-9","DOI":"10.1016\/S1470-2045(16)30500-9"},{"key":"1176_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol."},{"key":"1176_CR9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol"},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ctrv.2011.08.002","volume":"38","author":"M Peeters","year":"2012","unstructured":"Peeters M, Price T. Biologic therapies in the metastatic colorectal cancer treatment continuum\u2013applying current evidence to clinical practice. Cancer Treat Rev. 2012;38:397\u2013406.","journal-title":"Cancer Treat Rev"},{"key":"1176_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg"},{"key":"1176_CR12","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392.","journal-title":"J Clin Oncol"},{"key":"1176_CR13","first-page":"1840","volume":"44","author":"S Koga","year":"1984","unstructured":"Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osaki Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res. 1984;44:1840\u20132.","journal-title":"Cancer Res"},{"key":"1176_CR14","first-page":"207","volume":"41","author":"D Elias","year":"1994","unstructured":"Elias D, Detroz B, Debaene B, Damia E, Leclercq B, Rougier R, Lasser P. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepato-Gastroenterol. 1994;41:207\u201313.","journal-title":"Hepato-Gastroenterol"},{"key":"1176_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","volume":"254","author":"F Quenet","year":"2011","unstructured":"Quenet F, Go\u00e9r\u00e9 D, Mehta SS, Roca L, Dumont F, Hessissen M, Saint-Aubert B, Elias D. Results of two Bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg. 2011;254:294\u2013301.","journal-title":"Ann Surg"},{"key":"1176_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.gene.2009.04.011","volume":"442","author":"M Elias","year":"2009","unstructured":"Elias M, Archibald JM. The RJL family of small GTPases is an ancient eukaryotic invention probably functionally associated with the flagellar apparatus. Gene. 2009;442:63\u201372.","journal-title":"Gene"},{"key":"1176_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol"},{"key":"1176_CR18","doi-asserted-by":"publisher","unstructured":"Ph S (2012) Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract.https:\/\/doi.org\/10.1155\/2012\/309417","DOI":"10.1155\/2012\/309417"},{"key":"1176_CR19","doi-asserted-by":"publisher","first-page":"168597","DOI":"10.1016\/j.scitotenv.2023.168597","volume":"909","author":"X Sun","year":"2023","unstructured":"Sun X, Wang X, Han Q, Yu Q, Wanyan R, Li H. Bibliometric analysis of papers on antibiotic resistance genes in aquatic environments on a global scale from 2012 to 2022: evidence from universality, development and harmfulness. Sci Total Environ. 2023;909:168597.","journal-title":"Sci Total Environ"},{"key":"1176_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jenvman.2023.119513","volume":"349","author":"N Liu","year":"2023","unstructured":"Liu N, Gao R, Xiao S, Xue B. Visualizing the bibliometrics of biochar research for remediation of arsenic pollution. J Environ Manage. 2023;349: 119513.","journal-title":"J Environ Manage"},{"key":"1176_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7:1\u201323.","journal-title":"Nat Rev Dis Primers"},{"key":"1176_CR22","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.1128\/spectrum.00135-23","volume":"11","author":"R Huang","year":"2023","unstructured":"Huang R, Yao Y, Tong X, et al. Tracing the evolving dynamics and research hotspots of microbiota and immune microenvironment from the past to the new era. Microbiol Spectr. 2023;11:e00135-23.","journal-title":"Microbiol Spectr"},{"key":"1176_CR23","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1111\/cns.14232","volume":"29","author":"H Zhu","year":"2023","unstructured":"Zhu H, Zhang Y, Feng S, Li Y, Ye Y, Jian Z, Xiong X, Gu L. Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: a bibliometric analysis. CNS Neuroscience & Therapeutics. 2023;29:2940\u201354.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"1176_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12951-023-02051-6","volume":"21","author":"F Zhiguo","year":"2023","unstructured":"Zhiguo F, Ji W, Shenyuan C, Guoyou Z, Chen K, Hui Q, Wenrong X, Zhai X. A swift expanding trend of extracellular vesicles in spinal cord injury research: a bibliometric analysis. J Nanobiotechnology. 2023;21:289.","journal-title":"J Nanobiotechnology"},{"key":"1176_CR25","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.3390\/cancers15123230","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yan L, Wang Z, Li F, Lv J, Liu J, Liu X, Bao L, Zhang Y. Bibliometric analysis of global research on tumor dormancy. Cancers. 2023;15:3230.","journal-title":"Cancers"},{"key":"1176_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523\u201338.","journal-title":"Scientometrics"},{"key":"1176_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14712598.2012.674507","volume":"12","author":"C Chen","year":"2012","unstructured":"Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12:593\u2013608.","journal-title":"Expert Opin Biol Ther"},{"key":"1176_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017;11:959\u201375.","journal-title":"J Informetr"},{"key":"1176_CR29","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.3390\/su15097281","volume":"15","author":"J Su","year":"2023","unstructured":"Su J, Wang M, Razi MAM, Dom NM, Sulaiman N, Tan L-W. A bibliometric review of nature-based solutions on urban stormwater management. Sustainability. 2023;15:7281.","journal-title":"Sustainability"},{"key":"1176_CR30","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41467-022-29630-9","volume":"13","author":"JM de Gooyer","year":"2022","unstructured":"de Gooyer JM, Elekonawo FMK, Bremers AJA, Boerman OC, Aarntzen EHJG, de Reuver PR, Nagtegaal ID, Rijpkema M, de Wilt JHW. Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin. Nat Commun. 2022;13:2621.","journal-title":"Nat Commun"},{"key":"1176_CR31","doi-asserted-by":"crossref","unstructured":"Hoogstins CE, Weixler B, Boogerd LS, et al. In search for optimal targets for intraoperative fluorescence imaging of peritoneal metastasis from colorectal cancer. Biomark Cancer. 2017; 9:1179299X1772825","DOI":"10.1177\/1179299X17728254"},{"key":"1176_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3816\/CCC.2002.n.009","volume":"2","author":"G Hajjar","year":"2002","unstructured":"Hajjar G, Sharkey RM, Burton J, Zhang C-H, Yeldell D, Matthies A, Alavi A, Losman MJ, Brenner A, Goldenberg DM. Phase I radioimmunotherapy trial with iodine-131\u2014labeled humanized MN-14 anti\u2014carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer. Clin Colorectal Cancer. 2002;2:31\u201342.","journal-title":"Clin Colorectal Cancer"},{"key":"1176_CR33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s12032-011-9967-z","volume":"29","author":"X-Q Yang","year":"2012","unstructured":"Yang X-Q, Chen C, Peng C-W, Liu S-P, Li Y. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19\u20139 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Med Oncol. 2012;29:1030\u20136.","journal-title":"Med Oncol"},{"key":"1176_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jjco\/29.11.550","volume":"29","author":"T Yamao","year":"1999","unstructured":"Yamao T, Kai S, Kazami A, Koizumi K, Handa T, Takemoto N, Maruyama M. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. Jpn J Clin Oncol. 1999;29:550\u20135.","journal-title":"Jpn J Clin Oncol"},{"key":"1176_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","volume":"20","author":"PL Wagner","year":"2013","unstructured":"Wagner PL, Austin F, Sathaiah M, et al. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013;20:506\u201314.","journal-title":"Ann Surg Oncol"},{"key":"1176_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/BF02574513","volume":"9","author":"S van Ruth","year":"2002","unstructured":"van Ruth S, Hart AAM, Bonfrer JMG, Verwaal VJ, Zoetmulder FAN. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002;9:961\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1176_CR37","first-page":"2311","volume":"22","author":"M Carpelan-Holmstr\u00f6m","year":"2002","unstructured":"Carpelan-Holmstr\u00f6m M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19\u20139 and CA 72\u20134 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22:2311\u20136.","journal-title":"Anticancer Res"},{"key":"1176_CR38","first-page":"2939","volume":"17","author":"G Gebauer","year":"1997","unstructured":"Gebauer G, M\u00fcller-Ruchholtz W. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Anticancer Res. 1997;17:2939\u201342.","journal-title":"Anticancer Res"},{"key":"1176_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/SLA.0000000000005856","volume":"278","author":"A Dhiman","year":"2023","unstructured":"Dhiman A, Kothary V, Witmer HDD, Bregio C, Sood D, Ong CT, Polite B, Eng OS, Shergill A, Turaga KK. Role of tumor-informed personalized circulating tumor DNA assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative-intent surgery. Ann Surg. 2023;278:925.","journal-title":"Ann Surg"},{"key":"1176_CR40","doi-asserted-by":"publisher","unstructured":"Diehl F, Schmidt K, Choti MA et al (2008) Circulating mutant DNA to assess tumor dynamics. Nature Med.https:\/\/doi.org\/10.1038\/nm.1789","DOI":"10.1038\/nm.1789"},{"key":"1176_CR41","doi-asserted-by":"publisher","unstructured":"Loupakis F, Sharma S, Derouazi M et al (2021) Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases. JCO precision oncology.https:\/\/doi.org\/10.1200\/PO.21.00101","DOI":"10.1200\/PO.21.00101"},{"key":"1176_CR42","doi-asserted-by":"crossref","unstructured":"Torresan S, de Scordilli M, Bortolot M, Di Nardo P, Foltran L, Fumagalli A, Guardascione M, Ongaro E, Puglisi F (2023) Liquid biopsy in colorectal cancer: onward and upward. Crit Rev Oncol Hematol 104242","DOI":"10.1016\/j.critrevonc.2023.104242"},{"key":"1176_CR43","doi-asserted-by":"publisher","unstructured":"Hu Q, Chen L, Li K, Liu R, Sun L, Han T (2023) Circulating tumor DNA: current implementation issues and future challenges for clinical utility. Clin Chem Lab Med.https:\/\/doi.org\/10.1515\/cclm-2023-1157","DOI":"10.1515\/cclm-2023-1157"},{"key":"1176_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/02656736.2017.1312563","volume":"33","author":"C Carlier","year":"2017","unstructured":"Carlier C, Mathys A, De Jaeghere E, Steuperaert M, De Wever O, Ceelen W. Tumour tissue transport after intraperitoneal anticancer drug delivery. Int J Hyperth. 2017;33:534\u201342.","journal-title":"Int J Hyperth"},{"key":"1176_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.trecan.2019.12.008","volume":"6","author":"W Ceelen","year":"2020","unstructured":"Ceelen W, Ramsay RG, Narasimhan V, Heriot AG, De Wever O. Targeting the tumor microenvironment in colorectal peritoneal metastases. Trends in Cancer. 2020;6:236\u201346.","journal-title":"Trends in Cancer"},{"key":"1176_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161:933\u201345.","journal-title":"Cell"},{"key":"1176_CR47","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/bjs.11206","volume":"106","author":"I Ubink","year":"2019","unstructured":"Ubink I, Bolhaqueiro ACF, Elias SG, et al. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg. 2019;106:1404\u201314.","journal-title":"Br J Surg"},{"key":"1176_CR48","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920\u20136.","journal-title":"Science"},{"key":"1176_CR49","doi-asserted-by":"publisher","unstructured":"Schutgens F, Clevers H (2020) Human organoids: tools for understanding biology and treating diseases. Annu Rev Pathol.https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032611","DOI":"10.1146\/annurev-pathmechdis-012419-032611"},{"key":"1176_CR50","doi-asserted-by":"crossref","unstructured":"Verissimo CS, Overmeer RM, Ponsioen B, et al Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. eLife 5:e18489","DOI":"10.7554\/eLife.18489"},{"key":"1176_CR51","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/bjs.11206","volume":"106","author":"I Ubink","year":"2019","unstructured":"Ubink I, Bolhaqueiro ACF, Elias SG, et al. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg. 2019;106:1404\u201314.","journal-title":"Br J Surg"},{"key":"1176_CR52","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","volume":"26","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Wright JA, Churchill M, et al. Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy. Clin Cancer Res. 2020;26:3662\u201370.","journal-title":"Clin Cancer Res"},{"key":"1176_CR53","unstructured":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31597751\/. Accessed 24 Dec 2023"},{"key":"1176_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/cgt.2016.14","volume":"23","author":"SC Katz","year":"2016","unstructured":"Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP. Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Therapy. 2016;23:142\u20138.","journal-title":"Cancer Gene Therapy"},{"key":"1176_CR55","doi-asserted-by":"publisher","first-page":"52207","DOI":"10.18632\/oncotarget.10537","volume":"7","author":"X Liang","year":"2016","unstructured":"Liang X, Luo M, Wei X-W, et al. A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy. Oncotarget. 2016;7:52207\u201317.","journal-title":"Oncotarget"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T07:29:21Z","timestamp":1737617361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01176-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"11 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"51"}}